Home/Filings/4/0001559058-14-000007
4//SEC Filing

NephroGenex, Inc. 4

Accession 0001559058-14-000007

CIK 0001338095operating

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:25 PM ET

Size

5.5 KB

Accession

0001559058-14-000007

Insider Transaction Report

Form 4
Period: 2014-12-12
Hamill John
Chief Financial Officer
Transactions
  • Award

    Options to Purchase Common Stock

    2014-12-12+45,00045,000 total
    Exercise: $4.67From: 2015-12-12Exp: 2018-12-12Common Stock (45,000 underlying)

Issuer

NephroGenex, Inc.

CIK 0001338095

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001338095

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:25 PM ET
Size
5.5 KB